Clinical Trials Logo

Filter by:
NCT ID: NCT04902079 Recruiting - Clinical trials for Heart Failure, Systolic

Observational and Prospective Registry on Cardiac Contractility Modulation (CCM) Therapy

REPORT-CCM
Start date: March 8, 2021
Phase:
Study type: Observational

Observational and perspective study with acute and chronic endpoint.

NCT ID: NCT04901806 Terminated - Solid Tumor, Adult Clinical Trials

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Start date: July 20, 2021
Phase: Phase 1
Study type: Interventional

This is a first-in-human, open-label, multicenter, dose-escalation, safety, PK, and biomarker study of PBI-200 in subjects with NTRK-fusion-positive advanced or metastatic solid tumors.

NCT ID: NCT04901585 Completed - Gastric Cancer Clinical Trials

Enterotomy Closure and Minimally Invasive Gastrectomy

Start date: January 1, 2009
Phase:
Study type: Observational

All consecutive patients from January 2009 to december 2019 who underwent minimally invasive partial gastrectomy for gastric cancer at thirteen high volume institutions will be retrospective analysed to assess the better way to fashion a handsewn intracorporeal enterotomy closure after a stapled anastomosis.

NCT ID: NCT04901273 Recruiting - Knee Osteoarthritis Clinical Trials

Homologous PRP vs Placebo in Knee Osteoarthritis in Over 65 Years Old Patients

Start date: December 15, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to compare the 6 months clinical outcome of the treatment with a single injection of Homologous PRP versus single injection of placebo (saline solution) in the infiltrative treatment of knee osteoarthritis in over 65 years old patients. The evaluation will be performed through clinical, subjective and objective assessments.

NCT ID: NCT04901195 Active, not recruiting - Clinical trials for Hidradenitis Suppurativa

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

BE HEARD EXT
Start date: May 27, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

NCT ID: NCT04900805 Completed - Healthy Clinical Trials

Temperature Variation During Meditative Practices

Start date: June 5, 2021
Phase:
Study type: Observational

The temperature on selected points of the hands has been monitored during meditative practices. The practitioner is in complete rest for the time of the measure, and only mental activity is carried out. The purpose is to verify if the heat sensation, that is normally felt, is a real, measurable physiological effect, or if it is just a subjective feeling. Quantitative data analysis is foreseen.

NCT ID: NCT04900558 Recruiting - Surgery Clinical Trials

Robotic Radical Cystectomy Outcomes

Start date: April 29, 2021
Phase:
Study type: Observational [Patient Registry]

Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery

NCT ID: NCT04900142 Recruiting - Clinical trials for Glaucoma, Open-Angle

Micropulsed Laser Trabeculoplasty Using Different Parameters

Start date: March 20, 2020
Phase: N/A
Study type: Interventional

This randomized, double blinded, clinical trial compares two different parameters setting of micropulsed laser trabeculoplasty for open angle glaucoma. Group one is treated with 1500 mW of Power, Group two with 1000 mW. The other settings (300 micron of diameter, 300 ms of duration, 15% duty cycle) are the same for both groups, and the laser is applied for 360°. The main outcome is to evaluate the IOP (IntraOcular Pressure) lowering effects of both treatments and the safety on the corneal endothelium.

NCT ID: NCT04900038 Terminated - HIV Infections Clinical Trials

A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

DYNAMIC
Start date: August 18, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the efficacy of GSK3640254 + DTG relative to lamivudine (3TC) + DTG in treatment-naïve adult participants living with human immunodeficiency virus (HIV)-1. The participants were randomized to one of the three doses of blinded GSK3640254 (100, 150, or 200 milligrams [mgs]) or a reference arm of blinded 3TC-each in combination with open label DTG.

NCT ID: NCT04899986 Completed - Clinical trials for Peri-implant Mucositis

Chlorhexidine Gel and Peribioma Periogel Use in Peri-implant Mucositis Sites: a Split-mouth Randomized Clinical Trial.

Start date: May 15, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of non-surgical periodontal therapy with supportive home oral care for the treatment of peri-implant mucositis. Patients with bilateral implants with peri-implant mucositis will undergo professional dental hygiene with ultrasonic handpiece and manual scaler, followed by the application of glycine Airflow powders. Then, patients will be randomly divided into two groups: the Trial Group will undergo a split-mouth application of chlorhexidine gel 1% for quadrants 1 and 4 and of Biorepair Periogel 0.12% for quadrants 2 and 3, with one daily home application for the following 15 days after the visits and the use of Biorepair Parodontogel toothpaste; the control Group will not use any gels. The improvement of peri-implant mucositis will be evaluated between the two groups and differences between the two gels will be assessed, if present.